If you take Ozempic, Wegovy, Mounjaro, or Zepbound, you may have seen the phrase “Ozempic mouth” online and wondered whether the medicine is damaging your teeth. The short answer is reassuring, and it is also more careful than most headlines. No source reviewed for this guide shows that these medicines directly damage teeth or enamel. What they can do, in some people, is change the conditions inside the mouth: less saliva, more reflux and vomiting, and different eating and drinking habits. Those changes, over time, can raise the risk of decay and enamel erosion.
This guide is written for a patient in the USA who takes, or is thinking about taking, one of these medicines. It explains what “Ozempic mouth” actually means, what the evidence does and does not prove, why reflux matters more than most people realise, what to tell your dentist, including before sedation, and a short daily routine that protects your teeth without asking you to stop a medicine that is helping you.
This guide is general information, not medical advice. Do not stop a GLP-1 medicine because of mouth symptoms without talking to your prescriber. If you have persistent vomiting, frequent reflux, or mouth pain, raise it with your prescriber and your dentist.
The short answer
“Ozempic mouth” is a nickname, not a diagnosis. It describes a cluster of mouth symptoms some people report while taking a GLP-1 medicine: dry mouth, altered taste, sensitivity, and enamel erosion. The medicine itself has not been shown to damage teeth directly. The risk is indirect. Dry mouth leaves less saliva to buffer acid and clear debris. Reflux and vomiting bring stomach acid up to the teeth, and stomach acid softens enamel. Dehydration and changes in what and how often you eat and drink add to the same picture.
Most people on these medicines do not develop new mouth problems. A large 2026 study of more than 226,000 GLP-1 users, compared with matched patients who were not on a GLP-1, found no increased risk for most mouth conditions. The one clear exception was acid reflux. That is the strongest link in the chain, and it is where most of the practical advice in this guide comes from.
If you take one of these medicines, tell your dentist. That one step matters more than any product you could buy. Your dentist can check for early erosion, talk about fluoride, and plan around sedation if you ever need it.
What “Ozempic mouth” means, and what it does not mean
The term is used in two different ways, and mixing them up causes most of the confusion. On this site, our May 2025 professional-angle post, ‘Ozempic mouth’: what do dental professionals must know?, uses the term for facial volume loss: rapid weight loss can reduce fat in the cheeks and the buccal area, which can make the face look sunken and can change how the smile looks. That post is written for dental professionals, and it is worth reading alongside this one if you want the professional view.
This guide uses the term the second way, the way patients usually mean it: the mouth symptoms themselves. Dry mouth. A metallic or altered taste. Teeth that feel sensitive to hot, cold, or sweet food. And, in some people, enamel erosion that a dentist can see before the patient feels it. None of these is a formal diagnosis. They are a cluster of reported symptoms, and they do not all appear together, and they do not appear in everyone.
That distinction matters because it changes what you should worry about. If the medicine directly attacked enamel, the answer would be to stop the medicine. The evidence points the other way. A 2026 comprehensive review of dental considerations for semaglutide, by Kofman and Ouanounou in the Canadian Journal of Diabetes, found that semaglutide does not exert cytotoxic or demineralizing effects on tooth structure. In plain words, the drug does not poison or dissolve tooth tissue by itself. The risk comes from the conditions around it: frequent gastric reflux, dehydration, and behaviour changes that create a high-risk oral environment.
A 2026 narrative review in the British Dental Journal, by O’Driscoll and McIntyre, reached a similar place. It found that dental evidence on GLP-1 medicines remains sparse. It did not establish direct tooth damage. Dry mouth and reduced saliva are possible safety signals, not confirmed common effects with a known causal mechanism. Sparse evidence is not the same as no risk. It means the honest answer, today, is that the direct link is unproven and the indirect links are real enough to act on.
What GLP-1 medicines do
GLP-1 medicines mimic a hormone your gut releases after eating. Semaglutide is sold as Ozempic for type 2 diabetes and Wegovy for weight loss. Tirzepatide is sold as Mounjaro for diabetes and Zepbound for weight loss. They slow how fast the stomach empties, reduce appetite, and help control blood sugar. Those same effects explain most of the mouth symptoms.
Slower stomach emptying is why nausea, vomiting, and reflux are the most common side effects, and why they are most common in the early weeks of therapy, when the dose is rising. The prescribing information for Ozempic, Wegovy, and Zepbound lists nausea and vomiting among the established adverse reactions. In Wegovy trials, nausea occurred in 44 percent of participants versus 16 percent on placebo, and vomiting in 24 percent versus 6 percent on placebo. For Ozempic in diabetes trials, secondary sources report nausea in 16 to 20 percent of participants and vomiting in 5 to 9 percent. Those Ozempic figures are reported ranges, not label tables, and they are given here only to show the scale: nausea is common, vomiting is less common, and both are most likely early on.
Eating less, and eating differently, is the point of the treatment, and it changes the mouth too. Some people drink less water without noticing. Some sip sweet drinks through the day to settle nausea. Some eat only one meal a day. Each of these is a small change on its own. Together, they change how often teeth sit in acid and how much saliva is there to protect them.
If you take one of these medicines for type 2 diabetes, the diabetes connection matters as well. Diabetes and gum disease affect each other in both directions, and that two-way link is explained in our guide on Diabetes and Gum Disease: The Two-Way Link, A1C, and What to Tell Your Dentist. A GLP-1 medicine does not cancel that link. It sits alongside it, which is one more reason your dentist should know what you take.
Dry mouth: what it feels like, and what the numbers do and do not prove
Dry mouth, called xerostomia by dentists, is the symptom patients report most often. It feels like a sticky mouth, trouble swallowing dry food, a tongue that sticks to the roof of the mouth, or a need to sip water to speak comfortably. It can also make food taste flat or odd, and it can make a denture or an aligner feel uncomfortable.
Saliva does more work than most people realise. The National Institute of Dental and Craniofacial Research explains that persistent dry mouth can increase the risk of tooth decay and oral infections, because saliva buffers acid, clears debris, and delivers calcium and phosphate that help remineralise enamel. When saliva runs low, acid stays on the teeth longer, food debris stays longer, and the repair work saliva normally does slows down. That is the mechanism to understand. It does not mean dry mouth always causes cavities. It means dry mouth removes a layer of protection, so other risks matter more.
How common is dry mouth on these medicines? The honest answer is that the figures conflict, and any guide that gives you one settled number is hiding that conflict. Here are the figures, each with its source label, so you can see why they differ.
A 2025 peer-reviewed continuing-education review (Geisinger, Dental Academy of CE, Nov 2025) puts dry mouth at about 1 percent in tirzepatide trials and up to 2 to 3 percent in post-marketing surveillance for semaglutide and liraglutide. Post-marketing surveillance counts reports that come in after a drug is in wide use, which is a different kind of number from a trial figure, and it is usually higher. A 2023 case series by Mawardi and colleagues described only three patients with semaglutide-associated hyposalivation, which is the clinical term for reduced saliva flow. Three patients is a signal worth noting, not a rate.
Then there is a large 2026 preprint by Marwaha and colleagues, from nference, posted on 24 Aug 2026. It followed 184,582 semaglutide or tirzepatide users for 12 months and found xerostomia was the most common newly documented oral condition, at 5.29 percent, and that 8.69 percent developed at least one new oral condition. It also found no significant overall increase in oral health problems versus comparators. That last part matters: the preprint found more newly documented dry mouth, but not more oral health problems overall. And the preprint is not peer reviewed, so its 5.29 percent figure should not be published or repeated as settled fact. It is the largest dataset available, and it is also the least finished. Both things are true at once.
There is one more check on the label side. Dry mouth is not listed among the most common adverse reactions in the May 2026 Ozempic prescribing information. Enamel destruction, tooth loss, and primary periodontal damage are absent from the established adverse reactions in the FDA prescribing information for Ozempic, Wegovy, and Zepbound. Absence from a label is not proof that a symptom never happens. It is evidence that, in the trials the label is built on, it was not common enough or clear enough to list that way. The reports patients give in clinics and online are real experiences. The trials and the reports are measuring different things, and both belong in an honest guide.
What should you take from this? If your mouth feels dry most of the day, take it seriously, even if no label lists it. Tell your dentist, drink water on a schedule rather than waiting until you feel thirsty, and do not assume a dry mouth will fix itself once the dose settles. If your mouth feels normal, do not go looking for a problem. The numbers say most people do not develop a new oral condition, and a dry mouth that comes and goes in the early weeks is not the same as persistent dry mouth.
Reflux and vomiting: the strongest link
If there is one section of this guide to remember, it is this one. Reflux is the risk the large 2026 data support most clearly. A large 2026 study of more than 226,000 GLP-1 users, compared with matched patients who were not on a GLP-1, found no increased risk for most mouth conditions. The one clear exception was acid reflux. Repeated vomiting or reflux exposes teeth to stomach acid, and stomach acid softening enamel is an established pathway to dental erosion. That chain, reflux to acid to erosion, is the strongest link in the whole picture, not proof that every user gets erosion.
Stomach acid is far stronger than anything you eat or drink. Enamel is the hardest tissue in the body, and it still softens when it sits in stomach acid. The erosion it causes is not a cavity. It is a slow thinning and smoothing of the enamel surface, often on the inside of the upper teeth first, where reflux acid pools. It can make teeth look yellow as the enamel thins and the dentine beneath shows through, and it can make teeth sensitive to hot, cold, and sweet food. A dentist can often spot it before you feel anything, which is why a checkup matters even when nothing hurts.
The pattern fits what dentists see in clinics. At SmileCon 2025, Kimberly Sanders, Pharm.D, told the American Dental Association that gastrointestinal side effects such as nausea, vomiting, and reflux are most common in the early weeks of therapy and can lower oral pH, promoting enamel erosion and changes to the oral microbiome. The ADA reported her session on 23 Oct 2025. Lower oral pH means a more acidic mouth, and an acidic mouth is a mouth where enamel softens and the bacteria that cause decay find it easier to work.
Vomiting deserves its own warning, because the instinct after vomiting is to brush immediately, and that instinct is wrong. Brushing right away scrubs acid-softened enamel. The standard advice, confirmed across the 2026 patient guides reviewed for this article, is to rinse first with water, or with a teaspoon of baking soda in water, wait about 30 minutes, and then brush with fluoride toothpaste. The wait is common dentist advice, not a proven rule: one in situ study (Ganss 2007, cited in a Nov 2026 evidence review) found the wait mattered far less than the fluoride itself. So if you cannot wait the full 30 minutes, rinse well and brush with fluoride toothpaste when you can. The fluoride is the part that matters most. What matters is that you do not brush on freshly softened enamel.
Reflux care is also prescriber care, not only dental care. If reflux is frequent, tell the prescriber who manages your GLP-1 medicine, as well as your dentist. Dose timing, food choices, and reflux treatment are decisions for the prescriber. The dentist can protect the teeth while those decisions are being made, but the dentist cannot stop the acid at its source.
Taste changes and sensitivity
Altered taste, called dysgeusia, is reported by some people on GLP-1 medicines. Food tastes metallic, or flat, or simply wrong. The taste change is usually tied to dry mouth: saliva carries flavour to the taste buds, and when saliva runs low, flavour dulls. It can also be tied to nausea, which changes what appeals to you and what turns your stomach. Taste changes are unpleasant, and they can push people toward sweeter or saltier food that feels easier to eat, which is itself a risk for teeth.
Sensitivity is the other common complaint. Teeth feel sharp pain with hot, cold, or sweet food, and the pain fades quickly when the trigger is gone. Sensitivity alone is not proof of damage. It can come from enamel that is thinning, from gums that have receded slightly, or from a dry mouth that leaves the tooth surface less protected. It can also come and go. What matters is the pattern. New sensitivity that lasts, or sensitivity in one tooth that keeps getting worse, is worth a dental visit on its own. General sensitivity that arrived with a new medicine and is slowly easing is worth mentioning at your next checkup, with the medicine named.
Do not try to diagnose erosion or decay from sensitivity alone. A dentist needs to look, and often to compare with earlier records, before saying whether enamel has thinned. That is also why telling the dentist about the medicine matters: the same sensitivity means something different in a person with frequent reflux than it does in a person whose only change is a new toothpaste.
What to tell your dentist, and before sedation
Tell your dentist you take a GLP-1 medicine, which one, and how long you have taken it. That sentence opens every useful conversation that follows. Mention the dose if it has changed recently, whether you have vomiting or reflux and how often, whether your mouth feels dry, and whether your eating and drinking habits have changed. If you take the medicine for type 2 diabetes, say so, because the diabetes and gum disease link changes what the dentist watches for. Our guide on Diabetes and Gum Disease explains that two-way link, and your dentist will already know it, but the dentist cannot act on it without knowing your medicines.
Before any sedation or general anesthesia, the disclosure matters even more. In late 2024, the FDA added a warning to GLP-1 labels about pulmonary aspiration during general anesthesia or deep sedation, because GLP-1 medicines slow gastric emptying and the stomach may still hold food when it is expected to be empty. Aspiration means stomach contents entering the lungs, and it is a serious risk. Multi-society guidance in Oct 2024 says most people can keep taking their GLP-1 before elective procedures, with a plan agreed with the team. That guidance does not mean you should decide for yourself. It means you, your prescriber, and your dental team agree a plan together, in advance. Do not stop the medicine on your own before a procedure. Tell the team, and let them decide.
The same disclosure applies to the sedation choices themselves. If you are weighing nitrous oxide, oral sedation, or IV sedation, the questions to ask before you book are in our guide on Dental Anxiety: Nitrous Oxide vs Oral Sedation vs IV Sedation. Read it with the GLP-1 disclosure in mind, and raise the medicine by name when you discuss the plan.
A practical point about checkups: some dentists suggest shorter intervals between visits, such as every 3 to 4 months, for GLP-1 patients with dry mouth or erosion risk. That is a suggestion to discuss with your dentist, not a rule or a guideline. The right interval depends on your mouth, your reflux, and what the dentist sees. Ask at your next visit whether your interval should change, and let the answer come from the examination, not from a number in an article.
How to protect your teeth: a short daily routine
Protection here is not complicated, and it does not need expensive products. It is a small set of habits, done consistently, that keep acid off the teeth and keep fluoride and saliva working.
Brush twice a day with fluoride toothpaste. Standard fluoride toothpaste holds about 1,450 ppm of fluoride, and that is the general figure for everyday use. If dry mouth or frequent vomiting is present, ask your dentist about prescription-strength fluoride. Prescription toothpaste, at 5,000 ppm, is a dentist decision, not a purchase to make on your own. Consider an alcohol-free fluoride rinse as well, because alcohol in a rinse dries the mouth further, which is the opposite of what you need.
After vomiting or reflux, rinse with water, or with a teaspoon of baking soda in water, wait about 30 minutes, and then brush with fluoride toothpaste. Do not brush right away on acid-softened enamel. If you cannot wait, rinse well and brush when you can, because the fluoride matters more than the exact wait.
Sip water through the day, on a schedule, rather than waiting for thirst. Chew sugar-free gum to stimulate saliva, which is one of the simplest ways to raise saliva flow without a prescription. Do not sip sweet drinks through the day to settle nausea, because that feeds decay: teeth sitting in sugar all day is one of the clearest routes to cavities. If nausea makes plain water hard to take, talk to your prescriber about it, rather than switching to sweet drinks by default.
Keep the fluoride routine steady even when eating is irregular. The fluoride amounts by age for children are different from the adult routine, and they are set out with a table in our guide on Your Child’s First Dental Visit. That guide is about children, and the adult routine here is simpler: brush twice daily with fluoride toothpaste, and let the dentist decide whether extra fluoride is needed.
Watch for gum trouble as well as enamel trouble. Bleeding gums, gums that look red or swollen, or a tooth that feels loose are worth a visit on their own. Gum disease and heart disease are linked in ways that are still being studied, and our guide on Gum Disease and Heart Disease explains the December 2025 AHA update. Catching gum trouble early is one of the cheapest wins in dentistry, and the same point is made in our guide on how early remedy of gum illness can save your smile.
When to call the dentist or the prescriber
Call your dentist sooner than your next routine visit if you notice any of these: persistent vomiting or frequent reflux; mouth sores that do not heal; new sensitivity that keeps getting worse, or sensitivity in one tooth; a chip or a crack you can feel with your tongue; a dry mouth that does not ease after the early weeks; or bleeding gums that do not settle with gentle brushing. None of these proves the medicine caused the problem. Each of them is a reason to look, rather than to wait.
Call your prescriber if vomiting or reflux is frequent, if you cannot keep water down, if nausea stops you eating for days, or if you are thinking about stopping the medicine because of mouth symptoms. Stopping a GLP-1 medicine has its own effects on blood sugar and weight, and that decision belongs with the prescriber, not with a symptom alone.
If you are between dentists, or your last visit was more than a year ago, starting a GLP-1 medicine is a good reason to book a checkup. The dentist can record what your enamel looks like now, so that any change later can be measured rather than guessed. That baseline is worth more than any single product.
The bottom line
Ozempic mouth is a real set of reported symptoms, and it is also a misleading name, because it sounds like a diagnosis and like proof of damage. The evidence, as it stands in Nov 2026, says the medicine does not directly damage teeth. It says dry mouth is a possible signal, not a confirmed common effect with a known mechanism. It says the large 2026 data found no increased risk for most mouth conditions, with acid reflux as the clear exception. And it says the practical risks, reflux, vomiting, dehydration, and changes in eating and drinking, are all things you and your dentist can act on.
So keep the medicine if your prescriber wants you on it. Tell your dentist you take it. Rinse after acid, wait, then brush with fluoride toothpaste. Sip water, chew sugar-free gum, and do not sip sweet drinks through the day. And if reflux is frequent, or your mouth stays dry, or a tooth starts to feel different, book a visit and say the medicine by name. The goal is not to fear the medicine. It is to protect your teeth while the medicine does its job.
Frequently asked questions
Does Ozempic damage teeth directly?
No source reviewed for this guide shows that semaglutide directly damages teeth or enamel. A 2026 review in the Canadian Journal of Diabetes found semaglutide does not exert cytotoxic or demineralizing effects on tooth structure. The risk is indirect: dry mouth, reflux, vomiting, dehydration, and eating and drinking changes create a high-risk oral environment. Enamel destruction, tooth loss, and primary periodontal damage are absent from the established adverse reactions in the FDA prescribing information for Ozempic, Wegovy, and Zepbound.
How common is dry mouth on Ozempic?
The figures conflict, so there is no one settled number. A 2025 peer-reviewed continuing-education review puts dry mouth at about 1 percent in tirzepatide trials and up to 2 to 3 percent in post-marketing surveillance for semaglutide and liraglutide. A large 2026 preprint, which is not peer reviewed, found xerostomia in 5.29 percent of 184,582 semaglutide or tirzepatide users over 12 months, with 8.69 percent developing at least one new oral condition, and no significant overall increase in oral health problems versus comparators. Dry mouth is not listed among the most common adverse reactions in the May 2026 Ozempic prescribing information. If your mouth feels dry most of the day, tell your dentist, whatever the figures say.
Can Ozempic cause cavities?
Ozempic does not cause cavities by itself. Cavities need acid, bacteria, and time, and the medicine changes the first of those by drying the mouth and by bringing stomach acid up through reflux and vomiting. Persistent dry mouth can increase the risk of tooth decay and oral infections, because saliva normally buffers acid, clears debris, and delivers calcium and phosphate for remineralisation. Brushing twice daily with fluoride toothpaste, sipping water through the day, and avoiding sweet drinks sipped through the day all lower that risk.
Should I brush right after vomiting?
No. Brushing right away scrubs acid-softened enamel. Rinse first with water, or with a teaspoon of baking soda in water, wait about 30 minutes, and then brush with fluoride toothpaste. The 30-minute wait is common dentist advice, not a proven rule, and one in situ study found the wait mattered far less than the fluoride itself. So if you cannot wait the full 30 minutes, rinse well and brush with fluoride toothpaste when you can.
Should I stop Ozempic before dental sedation?
Do not decide that on your own. In late 2024, the FDA added a warning to GLP-1 labels about pulmonary aspiration during general anesthesia or deep sedation, because these medicines slow gastric emptying. Multi-society guidance in Oct 2024 says most people can keep taking their GLP-1 before elective procedures, with a plan agreed with the team. Tell your dentist and your prescriber well before the procedure, name the medicine and the dose, and let them agree the plan together.
When should I see a dentist sooner?
Book sooner if you have persistent vomiting or frequent reflux, mouth sores that do not heal, new sensitivity that keeps getting worse, a chip or crack you can feel, a dry mouth that does not ease after the early weeks, or bleeding gums that do not settle. If you have just started a GLP-1 medicine and your last dental visit was more than a year ago, book a checkup so the dentist can record your enamel as a baseline.
This article is general information, not medical advice. It does not replace advice from your dentist or your prescriber. Do not stop a GLP-1 medicine because of mouth symptoms without talking to your prescriber. If you have persistent vomiting, frequent reflux, or mouth pain, raise it with your prescriber and your dentist.